Immune responses were about two-to-three-fold higher in adolescents than in adults against all variants studied. Vaccine was well-tolerated with no safety signals identified
Senior R&D leader from Pfizer and bluebird bio to support Strand’s platform of programmable mRNA-based therapeutics
This is the ninth Covid-19 vaccine approved in India
The recommendations have been sent to the Drugs Controller General of India (DCGI) for the final approval
Restasis has been approved for use in the U.S. for nearly 20 years, but until today, there was no approved generic product of this drug
Spikevax has received approval by regulators in more than 70 countries, including Canada, Japan, the European Union, the UK, Israel
The immunogens being tested in IAVI G002 were developed by scientific teams at IAVI and Scripps Research and will be delivered via Moderna's mRNA technology
KEYTRUDA is now approved as monotherapy for adults with Renal Cell Carcinoma (RCC)
This will evaluate the immunogenicity, safety, and reactogenicity of a single booster dose in adults aged 18 years and older
CEQUA’s nanomicellar (NCELL) technology improves the bioavailability and physicochemical stability of cyclosporine to increase ocular tissue penetration
Subscribe To Our Newsletter & Stay Updated
